文献速递生殖医学

首次临床流产的核型与后续妊娠结局的预后

Karyotype of first clinical miscarriage and prognosis of subsequent pregnancy outcome.
PubMed 文献 · Reprod Biomed Online · 2021-04-06

该回顾性队列研究纳入接受手动负压吸引及染色体检测的不孕患者,分析首次临床流产(索引妊娠)的核型与后续妊娠活产率的关系。临床流产和生化流产风险亦无显著差异。结论认为不孕患者首次临床流产后的预后与流产核型无关。

要点

  • 整倍体与非整倍体首次临床流产后,后续活产率无显著差异。
  • 核型不影响后续临床流产或生化流产的风险。
  • 不孕患者首次流产后预后总体良好,与核型无关。

核心结论

  • 不孕患者首次临床流产后,整倍体与非整倍体核型的后续妊娠预后同样良好,且与流产核型无关。

研究设计与样本

  • 回顾性队列研究,纳入1999至2018年两家学术附属生殖中心的不孕患者,均因首次临床流产行手动负压吸引及染色体检测,且有遗传诊断和后续妊娠,排除使用胚胎植入前非整倍体检测者。

主要发现

  • 整倍体流产组后续活产率为63%,非整倍体组为68%(aOR 0.75,95%CI 0.47-1.39,P=0.45)。
  • 后续临床流产率整倍体组32%,非整倍体组24%(aOR 1.49,95%CI 0.83-2.70,P=0.19)。
  • 后续生化流产率整倍体组5%,非整倍体组8%(aOR 0.46,95%CI 0.14-1.55,P=0.21)。

临床怎么用

  • 对于不孕患者首次临床流产,流产核型结果不应作为后续妊娠预后的独立预测因素。
  • 临床咨询时可告知患者,无论首次流产核型如何,后续妊娠活产机会均较为乐观。

局限性

  • 回顾性研究设计可能存在选择偏倚。
  • 样本来自两家学术附属生殖中心,外推性需谨慎。
  • 未报告其他潜在混杂因素的详细分析。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

RESEARCH QUESTION: Is the karyotype of the first clinical miscarriage in an infertile patient predictive of the outcome of the subsequent pregnancy? DESIGN: Retrospective cohort study of infertile patients undergoing manual vacuum aspiration with chromosome testing at the time of the first (index) clinical miscarriage with a genetic diagnosis and a subsequent pregnancy. Patients treated at two academic-affiliated fertility centres from 1999 to 2018 were included; those using preimplantation genetic testing for aneuploidy were excluded. Main outcome was live birth in the subsequent pregnancy. RESULTS: One hundred patients with euploid clinical miscarriage and 151 patients with aneuploid clinical miscarriage in the index pregnancy were included. Patients with euploid clinical miscarriage in the index pregnancy had a live birth rate of 63% in the subsequent pregnancy compared with 68% among patients with aneuploid clinical miscarriage (adjusted odds ratio [aOR] 0.75, 95% CI 0.47-1.39, P = 0.45, logistic regression model adjusting for age, parity, body mass index and mode of conception). In a multinomial logistic regression model with three outcomes (live birth, clinical miscarriage or biochemical miscarriage), euploid clinical miscarriage for the index pregnancy was associated with similar odds of clinical miscarriage in the subsequent pregnancy compared with aneuploid clinical miscarriage for the index pregnancy (32% versus 24%, respectively, aOR 1.49, 95% CI 0.83-2.70, P = 0.19). Euploid clinical miscarriage for the index pregnancy was not associated with likelihood of biochemical miscarriage in the subsequent pregnancy compared with aneuploid clinical miscarriage (5% versus 8%, respectively, aOR 0.46, 95% CI 0.14-1.55, P = 0.21). CONCLUSION: Prognosis after a first clinical miscarriage among infertile patients is equally favourable among patients with euploid and aneuploid karyotype, and independent of the karyotype of the pregnancy loss.

来源:Reprod Biomed Online,查看原文。版权归原作者所有。

引用

  1. Murugappan G, Leonard SA, Newman H, et al. Karyotype of first clinical miscarriage and prognosis of subsequent pregnancy outcome. Reprod Biomed Online. 2021. PMID: 33962906. doi:10.1016/j.rbmo.2021.03.021

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。